SFXN2 Inhibitors
Sideroflexin 2 (SFXN2) inhibitors refer to a class of chemical compounds that selectively target and impede the function of the protein sideroflexin 2, which is one of the five members of the sideroflexin family, a group of mitochondrial membrane proteins. SFXN2 has been implicated in the transport of serine, an amino acid that plays a critical role in various metabolic processes within the cell. The inhibitors of SFXN2 are specifically designed to bind to this protein and modulate its activity. The exact mechanism through which these inhibitors exert their effect is complex, involving the interruption of the normal function of SFXN2, which can influence the serine metabolism pathway and subsequently affect various intracellular processes.
The development and characterization of SFXN2 inhibitors involve intricate chemical and biological studies to ensure specificity and effectiveness in their action. These compounds typically exhibit a high affinity for the SFXN2 protein, and their interaction can be studied through a range of biochemical assays and techniques such as crystallography or nuclear magnetic resonance (NMR) spectroscopy. These methods help in understanding the binding sites, the nature of the inhibitor-protein interaction, and the conformational changes that occur upon binding. The chemical properties of SFXN2 inhibitors, such as solubility, stability, and reactivity, are crucial factors in their effectiveness at the molecular level. Additionally, the research into these inhibitors sheds light on the broader functions of the sideroflexin family and their roles within the mitochondrial matrix, opening new avenues to explore fundamental biological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
A glycolysis inhibitor that mimics glucose and leads to the inhibition of hexokinase. This could decrease ATP production, potentially impacting SFXN2 function as ATP may be required for its transport activity. | ||||||
Oligomycin | 1404-19-9 | sc-203342 sc-203342C | 10 mg 1 g | $149.00 $12495.00 | 18 | |
An inhibitor of ATP synthase in mitochondria. By inhibiting ATP production, it could indirectly affect the function of SFXN2 if ATP is necessary for its activity. | ||||||
Bongkrekic acid | 11076-19-0 | sc-205606 | 100 µg | $400.00 | 10 | |
An inhibitor of the adenine nucleotide translocase (ANT) in mitochondria. It prevents the exchange of ADP and ATP across the mitochondrial membrane, which could disturb the proton gradient affecting ATP synthesis and thereby potentially affecting SFXN2 function. | ||||||
Antimycin A | 1397-94-0 | sc-202467 sc-202467A sc-202467B sc-202467C | 5 mg 10 mg 1 g 3 g | $55.00 $63.00 $1675.00 $4692.00 | 51 | |
An inhibitor of complex III in the mitochondrial electron transport chain. It prevents the transfer of electrons from cytochrome b to cytochrome c1, potentially reducing ATP synthesis, which might indirectly impact SFXN2 activity if it relies on ATP. | ||||||
Carboxine | 5234-68-4 | sc-234286 | 250 mg | $21.00 | 1 | |
An inhibitor of succinate dehydrogenase (complex II) in the mitochondrial electron transport chain. This inhibition could decrease the production of reducing equivalents and ATP, possibly affecting SFXN2 function. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
An inhibitor of complex I in the mitochondrial electron transport chain. It disrupts the flow of electrons and the proton gradient, potentially affecting ATP production and indirectly SFXN2 function. | ||||||
2-Thenoyltrifluoroacetone | 326-91-0 | sc-251801 | 5 g | $37.00 | 1 | |
A complex II inhibitor that interferes with the mitochondrial electron transport chain, potentially diminishing the production of ATP and indirectly affecting SFXN2 function. | ||||||
Sodium azide | 26628-22-8 | sc-208393 sc-208393B sc-208393C sc-208393D sc-208393A | 25 g 250 g 1 kg 2.5 kg 100 g | $43.00 $155.00 $393.00 $862.00 $90.00 | 8 | |
An inhibitor of complex IV (cytochrome c oxidase) of the mitochondrial electron transport chain, which could reduce ATP synthesis, potentially impacting SFXN2 activity. | ||||||
STF 31 | 724741-75-7 | sc-364692 | 10 mg | $187.00 | 3 | |
An inhibitor of glucose transporter 1 (GLUT1), which could decrease intracellular glucose levels, thereby potentially impacting ATP production and indirectly affecting SFXN2 function. | ||||||